Thought Leadership
Article | June 01, 2012
Read more
"Technological gimmickry" or a novel non-infringing use?
Intellectual Property Magazine
Blog | May 18, 2012
Ongoing royalty same as jury verdict where circumstances had not changed
Fish & Richardson
Read more
Blog | May 15, 2012
EDTX Post-Trial Order on Multiple Issues: Ongoing Royalty Base and Payment of Ongoing Royalties; Supplemental Damages & Prejudgment Interest; Foreign Tax Laws; Extending Ongoing Royalties to Successors and Assigns; Stay of Supplemental Damages and Ongoing Royalties Pending Appeal
Fish & Richardson
Read more
Article | May 08, 2012
Read more
The America Invents Act and Its Importance to Patent Prosecution in the Biotech Sector
Industrial Biotechnology
Blog | May 07, 2012
Lost Profits Rejected Where Patentee Failed to Prove It "Would Have Made" a Competing Product Absent the Alleged Infringement
Fish & Richardson
Read more
Blog | May 04, 2012
CAFC: Matter of First Impression Settlement—Negotiations Are Discoverable
Fish & Richardson
Read more
Blog | May 04, 2012
NDCA Allows Use of Nash Bargaining as "Check" on Royalty Rate; Rejects Use of EMVR Because Accused Products only "Capable" of Infringement
Fish & Richardson
Read more
Blog | May 02, 2012
EDTX Allows Defendant's Damages Reduction Based on Foreign Sales But Disallows in Part Defendant's Government Sales Reduction
Fish & Richardson
Read more
Blog | April 25, 2012
Oracle v. Google: NDCA Rejects Conclusions by Court-Appointed Damages Expert Because They Failed to Account for the Value of the IP in Suit
Fish & Richardson
Read more
Article | March 13, 2012
Read more
Biosimilars vs. Generics - Major Differences in the Regulatory Model
Pharmaceutical Compliance Monitor